-
Product Insights
Tonghua Mine
The Tonghua Mine is a coal mine in China. It is currently in operation. Empower your strategies with our Tonghua Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital information...
-
Product Insights
Tonghua Thermal Power Plant
Tonghua Thermal Power Plant is a thermal project located in Jilin, China. The project is owned by Tonghua Thermal Power Co Ltd. The project came online in 2007. Empower your strategies with our Tonghua Thermal Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may...
-
Product Insights
Tonghua Xuangang Power Plant Phase II
Tonghua Xuangang Power Plant Phase II is a thermal project located in Shaanxi, China. The project is owned and being developed by Shanxi Zhangdian Tonghua Power Generation Co Ltd. The project is at the permitting stage. Empower your strategies with our Tonghua Xuangang Power Plant Phase II report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Company Insights
Innovation and Patenting activity of Tonghua Dongbao Pharmaceutical Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Tonghua Dongbao Pharmaceutical Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Insulin Aspart in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Insulin Aspart in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Insulin Aspart in Type 2 Diabetes Drug Details: Insulin Aspart...
-
Product Insights
Ascites – Drugs In Development, 2023
Global Markets Direct’s, ‘Ascites - Drugs In Development, 2023’, provides an overview of the Ascites pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ascites, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Gouty Arthritis (Gout) – Drugs In Development, 2023
Global Markets Direct’s, ‘Gouty Arthritis (Gout) - Drugs In Development, 2023’, provides an overview of the Gouty Arthritis (Gout) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Gouty Arthritis (Gout), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Musculoskeletal Inflammation – Drugs In Development, 2023
Global Markets Direct’s, ‘Musculoskeletal Inflammation - Drugs In Development, 2023’, provides an overview of the Musculoskeletal Inflammation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Musculoskeletal Inflammation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Plaque Psoriasis (Psoriasis Vulgaris) – Drugs In Development, 2023
Global Markets Direct’s, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Drugs In Development, 2023’, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Plaque Psoriasis (Psoriasis Vulgaris), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...